Menu
Search
|

Menu

Close
X

Illumina Inc ILMN.OQ (NASDAQ Stock Exchange Global Select Market)

311.15 USD
+2.05 (+0.66%)
As of Jul 20
chart
Previous Close 309.10
Open 309.69
Volume 345,854
3m Avg Volume 322,345
Today’s High 312.52
Today’s Low 309.00
52 Week High 312.52
52 Week Low 170.36
Shares Outstanding (mil) 146.30
Market Capitalization (mil) 29,871.53
Forward P/E 40.23
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.95 Mean rating from 19 analysts

KEY STATS

Revenue (mm, USD)
FY18
782
FY17
2,751
FY16
2,398
FY15
2,220
EPS (USD)
FY18
1.405
FY17
5.942
FY16
3.126
FY15
3.096
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
40.23
32.76
Price to Sales (TTM)
vs sector
12.01
5.73
Price to Book (MRQ)
vs sector
10.98
5.47
Price to Cash Flow (TTM)
vs sector
35.48
23.29
Total Debt to Equity (MRQ)
vs sector
43.24
16.84
LT Debt to Equity (MRQ)
vs sector
43.06
12.51
Return on Investment (TTM)
vs sector
18.76
14.61
Return on Equity (TTM)
vs sector
31.34
16.34

EXECUTIVE LEADERSHIP

Jay Flatley
Executive Chairman of the Board, Since 2016
Salary: $771,154.00
Bonus: --
Francis deSouza
President, Chief Executive Officer, Director, Since 2016
Salary: $799,558.00
Bonus: --
Sam Samad
Chief Financial Officer, Senior Vice President, Since 2016
Salary: --
Bonus: --
Marc Stapley
Executive Vice President, Chief Administrative Officer, Since 2016
Salary: $540,000.00
Bonus: --
Garret Hampton
Executive Vice President - Clinical Genomics, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

5200 Illumina Way
SAN DIEGO   CA   92122-4616

Phone: +1858.2024500

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

SPONSORED STORIES